Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

LinnCo Prices IPO Of 30.25 Mln Shares At $36.50 Per Share - Quick Facts

RELATED NEWS
Trade LINE now with 

LINN Energy LLC (LINE: Quote) announced the pricing of the initial public offering of 30.25 million common shares of LinnCo LLC (LNCO), a wholly-owned subsidiary of LINN Energy, at $36.50 per common share.

The common shares are expected to begin trading on the NASDAQ Global Select Market on October 12, 2012 under the ticker symbol "LNCO."

The underwriters have the option to purchase up to an additional 4.53 million common shares from LinnCo, at the same price, to cover over-allotments, if any.

The offering is expected to close on or about October 17, 2012, subject to customary closing conditions.

Click here to receive FREE breaking news email alerts for Linn Energy LLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.